15-48613055-A-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The ENST00000316623.10(FBN1):c.202T>A(p.Cys68Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C68R) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000316623.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.202T>A | p.Cys68Ser | missense_variant | 3/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.202T>A | p.Cys68Ser | missense_variant | 2/65 | NP_001393645.1 | ||
FBN1 | NM_001406717.1 | c.202T>A | p.Cys68Ser | missense_variant | 3/9 | NP_001393646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.202T>A | p.Cys68Ser | missense_variant | 3/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 | |
FBN1 | ENST00000559133.6 | c.202T>A | p.Cys68Ser | missense_variant, NMD_transcript_variant | 3/67 | 1 | ENSP00000453958 | |||
FBN1 | ENST00000674301.2 | c.202T>A | p.Cys68Ser | missense_variant, NMD_transcript_variant | 3/68 | ENSP00000501333 | ||||
FBN1 | ENST00000537463.6 | c.202T>A | p.Cys68Ser | missense_variant, NMD_transcript_variant | 3/31 | 5 | ENSP00000440294 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2015 | The p.C68S variant (also known as c.202T>A), located in coding exon 2 of the FBN1 gene, results from a T to A substitution at nucleotide position 202. The cysteine at codon 68 is replaced by serine, an amino acid with dissimilar properties. In one study, this variant was detected in an individual with classicalMarfansyndrome, and it was ade novooccurrence (Stheneuret al.Eur J Hum Genet.2009;17(9):1121-1128). In addition, c.203G>C, another variant that results in the same p.C68S substitution in thiscysteine-richregion, was detected in an individual withectopialentis, minor skeletal system involvement and skin involvement (ComeglioP et al.HumMutat.2007;28(9):928). An alteration at the same amino acid position, p.C68F (also known as c.203G>T), was also reported in a Chinese patient presented with ectopia lentis, myopia, atrial septal defect, mild mitral valve regurgitation, pectuscarinatum, arachnodactyly and dental crowding (Jin C et al, Mol. Vis. 2007 ; 13():1280-4).This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6493 samples (12986 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at